Based on the induction of cell apoptosis and inhibition of cell proliferation by sulindac, we hypothesize that these functions of sulindac may be associated with increased JNK1 phosphorylation and suppression of β-catenin in human prostate cancer cells. Here, MAPK8 is linked to prostate carcinoma.